
[Data],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Lane,Sample_ID,Sample_Name,GenomeFolder,Index,bait_name,default_library_type,default_tag_sequence,default_tagtwo_sequence,email_addresses,email_addresses_of_followers,email_addresses_of_managers,email_addresses_of_owners,gbs_plex_name,is_control,is_pool,lane_id,lane_priority,library_name,organism,organism_taxon_id,project_cost_code,project_id,project_name,purpose,qc_state,request_id,required_insert_size_range,sample_accession_number,sample_cohort,sample_common_name,sample_consent_withdrawn,sample_control_type,sample_description,sample_donor_id,sample_id,sample_is_control,sample_name,sample_public_name,sample_reference_genome,sample_supplier_name,spiked_phix_tag_index,study_accession_number,study_alignments_in_bam,study_contains_nonconsented_human,study_contains_nonconsented_xahuman,study_description,study_id,study_name,study_reference_genome,study_separate_y_chromosome_data,study_title,tag_index,
1,441194,ERS011359,,ATCACGTTAT,,Standard,ATCACGTTAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR1 441194,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011359,,Streptococcus pneumoniae,,,,,135414,,TR1,TR1,,,,ERP000241,1,0,0,For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Bordetella_bronchiseptica (RB50),,Streptococcus pneumoniae transcriptomics,1,
1,441195,ERS011360,,CGATGTTTAT,,Standard,CGATGTTTAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR2 441195,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011360,,Streptococcus pneumoniae,,,,,135415,,TR2,TR2,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,2,
1,441196,ERS011361,,TTAGGCATAT,,Standard,TTAGGCATAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR3 441196,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011361,,Streptococcus pneumoniae,,,,,135416,,TR3,TR3,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,3,
1,441197,ERS011362,,TGACCACTAT,,Standard,TGACCACTAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR4 441197,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011362,,Streptococcus pneumoniae,,,,,135417,,TR4,TR4,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,4,
1,441198,ERS011363,,ACAGTGGTAT,,Standard,ACAGTGGTAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR5 441198,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011363,,Streptococcus pneumoniae,,,,,135418,,TR5,TR5,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,5,
1,441199,ERS011364,,GCCAATGTAT,,Standard,GCCAATGTAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR7 441199,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011364,,Streptococcus pneumoniae,,,,,135419,,TR7,TR7,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,6,
1,441200,ERS011365,,CAGATCTGAT,,Standard,CAGATCTGAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR8 441200,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011365,,Streptococcus pneumoniae,,,,,135420,,TR8,TR8,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,7,
1,441201,ERS011366,,ACTTGATGAT,,Standard,ACTTGATGAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR9 441201,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011366,,Streptococcus pneumoniae,,,,,135421,,TR9,TR9,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,8,
1,441202,ERS011367,,GATCAGCGAT,,Standard,GATCAGCGAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR10 441202,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011367,,Streptococcus pneumoniae,,,,,135422,,TR10,TR10,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,9,
1,441203,ERS011368,,TAGCTTGTAT,,Standard,TAGCTTGTAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR11 441203,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011368,,Streptococcus pneumoniae,,,,,135423,,TR11,TR11,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,10,
1,441204,ERS011369,,GGCTACAGAT,,Standard,GGCTACAGAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR12 441204,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011369,,Streptococcus pneumoniae,,,,,135424,,TR12,TR12,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,11,
1,441205,ERS011370,,CTTGTACTAT,,Standard,CTTGTACTAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR13 441205,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011370,,Streptococcus pneumoniae,,,,,135425,,TR13,TR13,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,12,
2,441275,ERS011383,,ATCACGTTAT,,Standard,ATCACGTTAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR31 441275,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011383,,Streptococcus pneumoniae,,,,,135438,,TR31,TR31,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,1,
2,441276,ERS011384,,CGATGTTTAT,,Standard,CGATGTTTAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR32 441276,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011384,,Streptococcus pneumoniae,,,,,135439,,TR32,TR32,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,2,
2,441277,ERS011385,,TTAGGCATAT,,Standard,TTAGGCATAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR33 441277,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011385,,Streptococcus pneumoniae,,,,,135440,,TR33,TR33,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,3,
2,441278,ERS011386,,TGACCACTAT,,Standard,TGACCACTAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR34 441278,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011386,,Streptococcus pneumoniae,,,,,135441,,TR34,TR34,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,4,
2,441279,ERS011387,,ACAGTGGTAT,,Standard,ACAGTGGTAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR35 441279,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011387,,Streptococcus pneumoniae,,,,,135442,,TR35,TR35,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,5,
2,441280,ERS011388,,GCCAATGTAT,,Standard,GCCAATGTAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR36 441280,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011388,,Streptococcus pneumoniae,,,,,135443,,TR36,TR36,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,6,
2,441281,ERS011389,,CAGATCTGAT,,Standard,CAGATCTGAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR37 441281,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011389,,Streptococcus pneumoniae,,,,,135444,,TR37,TR37,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,7,
2,441282,ERS011390,,ACTTGATGAT,,Standard,ACTTGATGAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR38 441282,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011390,,Streptococcus pneumoniae,,,,,135445,,TR38,TR38,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,8,
2,441283,ERS011391,,GATCAGCGAT,,Standard,GATCAGCGAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR39 441283,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011391,,Streptococcus pneumoniae,,,,,135446,,TR39,TR39,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,9,
2,441284,ERS011392,,TAGCTTGTAT,,Standard,TAGCTTGTAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR42 441284,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011392,,Streptococcus pneumoniae,,,,,135447,,TR42,TR42,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,10,
2,441285,ERS011393,,GGCTACAGAT,,Standard,GGCTACAGAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR43 441285,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011393,,Streptococcus pneumoniae,,,,,135448,,TR43,TR43,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,11,
2,441286,ERS011394,,CTTGTACTAT,,Standard,CTTGTACTAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR44 441286,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011394,,Streptococcus pneumoniae,,,,,135449,,TR44,TR44,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,12,
3,441309,ERS011395,,ATCACGTTAT,,Standard,ATCACGTTAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR45 441309,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011395,,Streptococcus pneumoniae,,,,,135450,,TR45,TR45,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,1,
3,441310,ERS011396,,CGATGTTTAT,,Standard,CGATGTTTAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR46 441310,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011396,,Streptococcus pneumoniae,,,,,135451,,TR46,TR46,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,2,
3,441311,ERS011397,,TTAGGCATAT,,Standard,TTAGGCATAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR47 441311,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011397,,Streptococcus pneumoniae,,,,,135452,,TR47,TR47,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,3,
3,441312,ERS011398,,TGACCACTAT,,Standard,TGACCACTAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR48 441312,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011398,,Streptococcus pneumoniae,,,,,135453,,TR48,TR48,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,4,
3,441313,ERS011399,,ACAGTGGTAT,,Standard,ACAGTGGTAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR49 441313,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011399,,Streptococcus pneumoniae,,,,,135454,,TR49,TR49,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,5,
3,441314,ERS011400,,GCCAATGTAT,,Standard,GCCAATGTAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR50 441314,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011400,,Streptococcus pneumoniae,,,,,135455,,TR50,TR50,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,6,
3,441315,ERS011401,,CAGATCTGAT,,Standard,CAGATCTGAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR51 441315,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011401,,Streptococcus pneumoniae,,,,,135456,,TR51,TR51,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,7,
3,441316,ERS011402,,ACTTGATGAT,,Standard,ACTTGATGAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR52 441316,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011402,,Streptococcus pneumoniae,,,,,135457,,TR52,TR52,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,8,
3,441317,ERS011403,,GATCAGCGAT,,Standard,GATCAGCGAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR53 441317,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011403,,Streptococcus pneumoniae,,,,,135458,,TR53,TR53,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,9,
3,441318,ERS011404,,TAGCTTGTAT,,Standard,TAGCTTGTAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR54 441318,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011404,,Streptococcus pneumoniae,,,,,135459,,TR54,TR54,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,10,
3,441319,ERS011405,,GGCTACAGAT,,Standard,GGCTACAGAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR55 441319,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011405,,Streptococcus pneumoniae,,,,,135460,,TR55,TR55,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,11,
3,441320,ERS011406,,CTTGTACTAT,,Standard,CTTGTACTAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR56 441320,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011406,,Streptococcus pneumoniae,,,,,135461,,TR56,TR56,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,12,
4,79578,Multiplex-phix,,,,,,,,,,,,1,0,,0,Multiplex-phix,,,,,,standard,,575637,,,,,,,,,9837,,Multiplex-phix,,,,,,1,0,0,None,198,Illumina Controls,,,,,
5,441361,ERS011407,,ATCACGTTAT,,Standard,ATCACGTTAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR57 441361,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011407,,Streptococcus pneumoniae,,,,,135462,,TR57,TR57,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,1,
5,441362,ERS011408,,CGATGTTTAT,,Standard,CGATGTTTAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR60 441362,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011408,,Streptococcus pneumoniae,,,,,135463,,TR60,TR60,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,2,
5,441363,ERS011409,,TTAGGCATAT,,Standard,TTAGGCATAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR61 441363,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011409,,Streptococcus pneumoniae,,,,,135464,,TR61,TR61,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,3,
5,441364,ERS011410,,TGACCACTAT,,Standard,TGACCACTAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR62 441364,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011410,,Streptococcus pneumoniae,,,,,135465,,TR62,TR62,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,4,
5,441365,ERS011411,,ACAGTGGTAT,,Standard,ACAGTGGTAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR63 441365,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011411,,Streptococcus pneumoniae,,,,,135466,,TR63,TR63,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,5,
5,441366,ERS011412,,GCCAATGTAT,,Standard,GCCAATGTAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR64 441366,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011412,,Streptococcus pneumoniae,,,,,135467,,TR64,TR64,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,6,
5,441367,ERS011413,,CAGATCTGAT,,Standard,CAGATCTGAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR65 441367,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011413,,Streptococcus pneumoniae,,,,,135468,,TR65,TR65,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,7,
5,441368,ERS011414,,ACTTGATGAT,,Standard,ACTTGATGAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR66 441368,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011414,,Streptococcus pneumoniae,,,,,135469,,TR66,TR66,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,8,
5,441369,ERS011415,,GATCAGCGAT,,Standard,GATCAGCGAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR68 441369,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011415,,Streptococcus pneumoniae,,,,,135470,,TR68,TR68,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,9,
5,441370,ERS011416,,TAGCTTGTAT,,Standard,TAGCTTGTAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR69 441370,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011416,,Streptococcus pneumoniae,,,,,135471,,TR69,TR69,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,10,
5,441371,ERS011417,,GGCTACAGAT,,Standard,GGCTACAGAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR70 441371,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011417,,Streptococcus pneumoniae,,,,,135472,,TR70,TR70,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,11,
5,441372,ERS011418,,CTTGTACTAT,,Standard,CTTGTACTAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR71 441372,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011418,,Streptococcus pneumoniae,,,,,135473,,TR71,TR71,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,12,
6,440850,ERS011419,,ATCACGTTAT,,Standard,ATCACGTTAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR72 440850,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011419,,Streptococcus pneumoniae,,,,,135474,,TR72,TR72,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,1,
6,440851,ERS011420,,CGATGTTTAT,,Standard,CGATGTTTAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR73 440851,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011420,,Streptococcus pneumoniae,,,,,135475,,TR73,TR73,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,2,
6,440852,ERS011421,,TTAGGCATAT,,Standard,TTAGGCATAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR74 440852,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011421,,Streptococcus pneumoniae,,,,,135476,,TR74,TR74,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,3,
6,440853,ERS011422,,TGACCACTAT,,Standard,TGACCACTAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR76 440853,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011422,,Streptococcus pneumoniae,,,,,135477,,TR76,TR76,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,4,
6,440854,ERS011423,,ACAGTGGTAT,,Standard,ACAGTGGTAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR77 440854,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011423,,Streptococcus pneumoniae,,,,,135478,,TR77,TR77,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,5,
6,440855,ERS011424,,GCCAATGTAT,,Standard,GCCAATGTAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR78 440855,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011424,,Streptococcus pneumoniae,,,,,135479,,TR78,TR78,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,6,
6,440856,ERS011425,,CAGATCTGAT,,Standard,CAGATCTGAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR79 440856,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011425,,Streptococcus pneumoniae,,,,,135480,,TR79,TR79,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,7,
6,440857,ERS011426,,ACTTGATGAT,,Standard,ACTTGATGAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR80 440857,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011426,,Streptococcus pneumoniae,,,,,135481,,TR80,TR80,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,8,
6,440858,ERS011427,,GATCAGCGAT,,Standard,GATCAGCGAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR81 440858,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011427,,Streptococcus pneumoniae,,,,,135482,,TR81,TR81,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,9,
6,440859,ERS011428,,TAGCTTGTAT,,Standard,TAGCTTGTAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR83 440859,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011428,,Streptococcus pneumoniae,,,,,135483,,TR83,TR83,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,10,
6,440860,ERS011429,,GGCTACAGAT,,Standard,GGCTACAGAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR85 440860,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011429,,Streptococcus pneumoniae,,,,,135484,,TR85,TR85,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,11,
6,440861,ERS011430,,CTTGTACTAT,,Standard,CTTGTACTAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR86 440861,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011430,,Streptococcus pneumoniae,,,,,135485,,TR86,TR86,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,12,
7,440902,ERS011431,,ATCACGTTAT,,Standard,ATCACGTTAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR87 440902,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011431,,Streptococcus pneumoniae,,,,,135486,,TR87,TR87,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,1,
7,440903,ERS011432,,CGATGTTTAT,,Standard,CGATGTTTAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR88 440903,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011432,,Streptococcus pneumoniae,,,,,135487,,TR88,TR88,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,2,
7,440904,ERS011433,,TTAGGCATAT,,Standard,TTAGGCATAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR89 440904,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011433,,Streptococcus pneumoniae,,,,,135488,,TR89,TR89,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,3,
7,440905,ERS011434,,TGACCACTAT,,Standard,TGACCACTAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR90 440905,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011434,,Streptococcus pneumoniae,,,,,135489,,TR90,TR90,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,4,
7,440906,ERS011435,,ACAGTGGTAT,,Standard,ACAGTGGTAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR91 440906,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011435,,Streptococcus pneumoniae,,,,,135490,,TR91,TR91,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,5,
7,440907,ERS011436,,GCCAATGTAT,,Standard,GCCAATGTAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR93 440907,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011436,,Streptococcus pneumoniae,,,,,135491,,TR93,TR93,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,6,
7,440908,ERS011437,,CAGATCTGAT,,Standard,CAGATCTGAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR94 440908,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011437,,Streptococcus pneumoniae,,,,,135492,,TR94,TR94,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,7,
7,440909,ERS011438,,ACTTGATGAT,,Standard,ACTTGATGAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR95 440909,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011438,,Streptococcus pneumoniae,,,,,135493,,TR95,TR95,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,8,
7,440910,ERS011439,,GATCAGCGAT,,Standard,GATCAGCGAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR96 440910,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011439,,Streptococcus pneumoniae,,,,,135494,,TR96,TR96,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,9,
7,440911,ERS011440,,TAGCTTGTAT,,Standard,TAGCTTGTAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR98 440911,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011440,,Streptococcus pneumoniae,,,,,135495,,TR98,TR98,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,10,
7,440912,ERS011441,,GGCTACAGAT,,Standard,GGCTACAGAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR99 440912,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011441,,Streptococcus pneumoniae,,,,,135496,,TR99,TR99,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,11,
7,440913,ERS011442,,CTTGTACTAT,,Standard,CTTGTACTAT,,deh@sanger.ac.uk dw2@sanger.ac.uk nc3@sanger.ac.uk tfelt@sanger.ac.uk,deh@sanger.ac.uk nc3@sanger.ac.uk,dw2@sanger.ac.uk,tfelt@sanger.ac.uk,,0,0,,,TR100 440913,Streptococcus pneumoniae,1313,S0700,136,Pneumo transcript 1,standard,,,from:150 to:250,ERS011442,,Streptococcus pneumoniae,,,,,135497,,TR100,TR100,,,,ERP000241,1,0,0,http%3A%2F%2Fwww.sanger.ac.uk%2Fresources%2Fdownloads%2Fbacteria%2Fstreptococcus-pneumoniae.html. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria)%2C please see http%3A%2F%2Fwww.sanger.ac.uk%2Fdatasharing%2F,136,Streptococcus pneumoniae transcriptomics,Streptococcus_pneumoniae (ATCC_700669),,Streptococcus pneumoniae transcriptomics,12,
8,441493,EGAN00001000013,,ATCACGTT,,Custom,ATCACGTT,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4229a 441493,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000013,,Homo sapiens,,,,,264378,,PD4229a,PD4229a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,1,
8,441494,EGAN00001000014,,CGATGTTT,,Custom,CGATGTTT,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4230a 441494,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000014,,Homo sapiens,,,,,264379,,PD4230a,PD4230a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,2,
8,441495,EGAN00001000015,,TTAGGCAT,,Custom,TTAGGCAT,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4231a 441495,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000015,,Homo sapiens,,,,,264380,,PD4231a,PD4231a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,3,
8,441496,EGAN00001000016,,TGACCACT,,Custom,TGACCACT,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4232a 441496,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000016,,Homo sapiens,,,,,264381,,PD4232a,PD4232a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,4,
8,441497,EGAN00001000017,,ACAGTGGT,,Custom,ACAGTGGT,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4233a 441497,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000017,,Homo sapiens,,,,,264382,,PD4233a,PD4233a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,5,
8,441498,EGAN00001000018,,GCCAATGT,,Custom,GCCAATGT,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4234a 441498,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000018,,Homo sapiens,,,,,264383,,PD4234a,PD4234a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,6,
8,441499,EGAN00001000019,,CAGATCTG,,Custom,CAGATCTG,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4235a 441499,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000019,,Homo sapiens,,,,,264384,,PD4235a,PD4235a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,7,
8,441500,EGAN00001000020,,ACTTGATG,,Custom,ACTTGATG,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4236a 441500,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000020,,Homo sapiens,,,,,264385,,PD4236a,PD4236a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,8,
8,441501,EGAN00001000021,,GATCAGCG,,Custom,GATCAGCG,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4237a 441501,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000021,,Homo sapiens,,,,,264386,,PD4237a,PD4237a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,9,
8,441502,EGAN00001000022,,TAGCTTGT,,Custom,TAGCTTGT,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4238a 441502,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000022,,Homo sapiens,,,,,264387,,PD4238a,PD4238a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,10,
8,441503,EGAN00001000023,,GGCTACAG,,Custom,GGCTACAG,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4239a 441503,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000023,,Homo sapiens,,,,,264388,,PD4239a,PD4239a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,11,
8,441504,EGAN00001000024,,CTTGTACT,,Custom,CTTGTACT,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4247a 441504,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000024,,Homo sapiens,,,,,264389,,PD4247a,PD4247a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,12,
8,441505,EGAN00001000025,,TGGTTGTT,,Custom,TGGTTGTT,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4249a 441505,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000025,,Homo sapiens,,,,,264390,,PD4249a,PD4249a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,13,
8,441506,EGAN00001000026,,TCTCGGTT,,Custom,TCTCGGTT,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4253a 441506,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000026,,Homo sapiens,,,,,264391,,PD4253a,PD4253a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,14,
8,441507,EGAN00001000031,,TAAGCGTT,,Custom,TAAGCGTT,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4355a 441507,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000031,,Homo sapiens,,,,,264392,,PD4355a,PD4355a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,15,
8,441508,EGAN00001000032,,TCCGTCTT,,Custom,TCCGTCTT,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4356a 441508,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000032,,Homo sapiens,,,,,264393,,PD4356a,PD4356a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,16,
8,441509,EGAN00001000027,,TGTACCTT,,Custom,TGTACCTT,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4357a 441509,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000027,,Homo sapiens,,,,,264394,,PD4357a,PD4357a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,17,
8,441510,EGAN00001000028,,TTCTGTGT,,Custom,TTCTGTGT,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4358a 441510,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000028,,Homo sapiens,,,,,264395,,PD4358a,PD4358a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,18,
8,441511,EGAN00001000029,,TCTGCTGT,,Custom,TCTGCTGT,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4359a 441511,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000029,,Homo sapiens,,,,,264396,,PD4359a,PD4359a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,19,
8,441512,EGAN00001000030,,TTGGAGGT,,Custom,TTGGAGGT,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4360a 441512,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000030,,Homo sapiens,,,,,264397,,PD4360a,PD4360a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,20,
8,441513,EGAN00001000035,,TCGAGCGT,,Custom,TCGAGCGT,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4361a 441513,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000035,,Homo sapiens,,,,,264398,,PD4361a,PD4361a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,21,
8,441514,EGAN00001000036,,TGATACGT,,Custom,TGATACGT,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4362a 441514,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000036,,Homo sapiens,,,,,264399,,PD4362a,PD4362a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,22,
8,441515,EGAN00001000037,,TGCATAGT,,Custom,TGCATAGT,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4363a 441515,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000037,,Homo sapiens,,,,,264400,,PD4363a,PD4363a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,23,
8,441516,EGAN00001000038,,TTGACTCT,,Custom,TTGACTCT,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4364a 441516,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000038,,Homo sapiens,,,,,264401,,PD4364a,PD4364a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,24,
8,441517,EGAN00001000033,,TGCGATCT,,Custom,TGCGATCT,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4365a 441517,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000033,,Homo sapiens,,,,,264402,,PD4365a,PD4365a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,25,
8,441518,EGAN00001000034,,TTCCTGCT,,Custom,TTCCTGCT,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4366a 441518,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000034,,Homo sapiens,,,,,264403,,PD4366a,PD4366a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,26,
8,441519,EGAN00001000039,,TAGTGACT,,Custom,TAGTGACT,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4367a 441519,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000039,,Homo sapiens,,,,,264404,,PD4367a,PD4367a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,27,
8,441520,EGAN00001000040,,TACAGGAT,,Custom,TACAGGAT,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4368a 441520,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000040,,Homo sapiens,,,,,264405,,PD4368a,PD4368a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,28,
8,441521,EGAN00001000041,,TCCTCAAT,,Custom,TCCTCAAT,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4369a 441521,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000041,,Homo sapiens,,,,,264406,,PD4369a,PD4369a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,29,
8,441522,EGAN00001000042,,TGTGGTTG,,Custom,TGTGGTTG,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4370a 441522,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000042,,Homo sapiens,,,,,264407,,PD4370a,PD4370a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,30,
8,441523,EGAN00001000043,,TAGTCTTG,,Custom,TAGTCTTG,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4371a 441523,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000043,,Homo sapiens,,,,,264408,,PD4371a,PD4371a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,31,
8,441524,EGAN00001000044,,TTCCATTG,,Custom,TTCCATTG,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4372a 441524,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000044,,Homo sapiens,,,,,264409,,PD4372a,PD4372a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,32,
8,441525,EGAN00001000045,,TCGAAGTG,,Custom,TCGAAGTG,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4373a 441525,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000045,,Homo sapiens,,,,,264410,,PD4373a,PD4373a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,33,
8,441526,EGAN00001000046,,TAACGCTG,,Custom,TAACGCTG,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4374a 441526,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000046,,Homo sapiens,,,,,264411,,PD4374a,PD4374a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,34,
8,441527,EGAN00001000047,,TTGGTATG,,Custom,TTGGTATG,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4375a 441527,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000047,,Homo sapiens,,,,,264412,,PD4375a,PD4375a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,35,
8,441528,EGAN00001000048,,TGAACTGG,,Custom,TGAACTGG,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4376a 441528,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000048,,Homo sapiens,,,,,264413,,PD4376a,PD4376a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,36,
8,441529,EGAN00001000049,,TACTTCGG,,Custom,TACTTCGG,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4377a 441529,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000049,,Homo sapiens,,,,,264414,,PD4377a,PD4377a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,37,
8,441530,EGAN00001000050,,TCTCACGG,,Custom,TCTCACGG,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4378a 441530,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000050,,Homo sapiens,,,,,264415,,PD4378a,PD4378a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,38,
8,441531,EGAN00001000055,,TCAGGAGG,,Custom,TCAGGAGG,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4379a 441531,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000055,,Homo sapiens,,,,,264416,,PD4379a,PD4379a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,39,
8,441532,EGAN00001000056,,TAAGTTCG,,Custom,TAAGTTCG,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4380a 441532,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000056,,Homo sapiens,,,,,264417,,PD4380a,PD4380a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,40,
8,441533,EGAN00001000051,,TCCAGTCG,,Custom,TCCAGTCG,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4381a 441533,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000051,,Homo sapiens,,,,,264418,,PD4381a,PD4381a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,41,
8,441534,EGAN00001000052,,TGTATGCG,,Custom,TGTATGCG,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4382a 441534,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000052,,Homo sapiens,,,,,264419,,PD4382a,PD4382a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,42,
8,441535,EGAN00001000053,,TCATTGAG,,Custom,TCATTGAG,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4383a 441535,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000053,,Homo sapiens,,,,,264420,,PD4383a,PD4383a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,43,
8,441536,EGAN00001000054,,TGGCTCAG,,Custom,TGGCTCAG,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4384a 441536,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000054,,Homo sapiens,,,,,264421,,PD4384a,PD4384a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,44,
8,441537,EGAN00001000058,,TATGCCAG,,Custom,TATGCCAG,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4385a 441537,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000058,,Homo sapiens,,,,,264422,,PD4385a,PD4385a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,45,
8,441538,EGAN00001000059,,TCAGATTC,,Custom,TCAGATTC,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4386a 441538,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000059,,Homo sapiens,,,,,264423,,PD4386a,PD4386a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,46,
8,441539,EGAN00001000060,,TACTAGTC,,Custom,TACTAGTC,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4387a 441539,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000060,,Homo sapiens,,,,,264424,,PD4387a,PD4387a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,47,
8,441540,EGAN00001000061,,TTCAGCTC,,Custom,TTCAGCTC,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4388a 441540,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000061,,Homo sapiens,,,,,264425,,PD4388a,PD4388a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,48,
8,441541,EGAN00001000057,,TGTCTATC,,Custom,TGTCTATC,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4389a 441541,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000057,,Homo sapiens,,,,,264426,,PD4389a,PD4389a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,49,
8,441542,EGAN00001000062,,TATGTGGC,,Custom,TATGTGGC,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4390a 441542,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000062,,Homo sapiens,,,,,264427,,PD4390a,PD4390a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,50,
8,441543,EGAN00001000063,,TTACTCGC,,Custom,TTACTCGC,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4391a 441543,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000063,,Homo sapiens,,,,,264428,,PD4391a,PD4391a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,51,
8,441544,EGAN00001000064,,TCGTTAGC,,Custom,TCGTTAGC,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4392a 441544,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000064,,Homo sapiens,,,,,264429,,PD4392a,PD4392a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,52,
8,441545,EGAN00001000065,,TACCGAGC,,Custom,TACCGAGC,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4393a 441545,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000065,,Homo sapiens,,,,,264430,,PD4393a,PD4393a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,53,
8,441546,EGAN00001000069,,TGTTCTCC,,Custom,TGTTCTCC,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4394a 441546,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000069,,Homo sapiens,,,,,264431,,PD4394a,PD4394a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,54,
8,441547,EGAN00001000070,,TTCGCACC,,Custom,TTCGCACC,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4395a 441547,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000070,,Homo sapiens,,,,,264432,,PD4395a,PD4395a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,55,
8,441548,EGAN00001000071,,TTGCGTAC,,Custom,TTGCGTAC,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4396a 441548,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000071,,Homo sapiens,,,,,264433,,PD4396a,PD4396a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,56,
8,441549,EGAN00001000066,,TCTACGAC,,Custom,TCTACGAC,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4397a 441549,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000066,,Homo sapiens,,,,,264434,,PD4397a,PD4397a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,57,
8,441550,EGAN00001000067,,TGACAGAC,,Custom,TGACAGAC,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4398a 441550,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000067,,Homo sapiens,,,,,264435,,PD4398a,PD4398a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,58,
8,441551,EGAN00001000068,,TAGAACAC,,Custom,TAGAACAC,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4399a 441551,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000068,,Homo sapiens,,,,,264436,,PD4399a,PD4399a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,59,
8,441552,EGAN00001000073,,TCATCCTA,,Custom,TCATCCTA,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4400a 441552,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000073,,Homo sapiens,,,,,264437,,PD4400a,PD4400a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,60,
8,441553,EGAN00001000074,,TGCTGATA,,Custom,TGCTGATA,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4401a 441553,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000074,,Homo sapiens,,,,,264438,,PD4401a,PD4401a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,61,
8,441554,EGAN00001000075,,TAGACGGA,,Custom,TAGACGGA,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4402a 441554,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000075,,Homo sapiens,,,,,264439,,PD4402a,PD4402a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,62,
8,441555,EGAN00001000076,,TGTGAAGA,,Custom,TGTGAAGA,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4403a 441555,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000076,,Homo sapiens,,,,,264440,,PD4403a,PD4403a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,63,
8,441556,EGAN00001000077,,TCTCTTCA,,Custom,TCTCTTCA,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4404a 441556,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000077,,Homo sapiens,,,,,264441,,PD4404a,PD4404a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,64,
8,441557,EGAN00001000072,,TTGTTCCA,,Custom,TTGTTCCA,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4405a 441557,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000072,,Homo sapiens,,,,,264442,,PD4405a,PD4405a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,65,
8,441558,EGAN00001000078,,TGAAGCCA,,Custom,TGAAGCCA,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4406a 441558,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000078,,Homo sapiens,,,,,264443,,PD4406a,PD4406a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,66,
8,441559,EGAN00001000079,,TACCACCA,,Custom,TACCACCA,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4407a 441559,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000079,,Homo sapiens,,,,,264444,,PD4407a,PD4407a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,67,
8,441560,EGAN00001000080,,TGCGTGAA,,Custom,TGCGTGAA,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4408a 441560,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000080,,Homo sapiens,,,,,264445,,PD4408a,PD4408a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,68,
8,441561,EGAN00001000081,,GGTGAGTT,,Custom,GGTGAGTT,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4409a 441561,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000081,,Homo sapiens,,,,,264446,,PD4409a,PD4409a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,69,
8,441562,EGAN00001000082,,GATCTCTT,,Custom,GATCTCTT,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4410a 441562,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000082,,Homo sapiens,,,,,264447,,PD4410a,PD4410a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,70,
8,441563,EGAN00001000083,,GTGTCCTT,,Custom,GTGTCCTT,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4411a 441563,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000083,,Homo sapiens,,,,,264448,,PD4411a,PD4411a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,71,
8,441564,EGAN00001000091,,GACGGATT,,Custom,GACGGATT,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4412a 441564,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000091,,Homo sapiens,,,,,264449,,PD4412a,PD4412a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,72,
8,441565,EGAN00001000084,,GCAACATT,,Custom,GCAACATT,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4413a 441565,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000084,,Homo sapiens,,,,,264450,,PD4413a,PD4413a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,73,
8,441566,EGAN00001000085,,GGTCGTGT,,Custom,GGTCGTGT,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4414a 441566,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000085,,Homo sapiens,,,,,264451,,PD4414a,PD4414a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,74,
8,441567,EGAN00001000086,,GAATCTGT,,Custom,GAATCTGT,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4415a 441567,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000086,,Homo sapiens,,,,,264452,,PD4415a,PD4415a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,75,
8,441568,EGAN00001000087,,GTACATCT,,Custom,GTACATCT,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4416a 441568,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000087,,Homo sapiens,,,,,264453,,PD4416a,PD4416a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,76,
8,441569,EGAN00001000088,,GAGGTGCT,,Custom,GAGGTGCT,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4417a 441569,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000088,,Homo sapiens,,,,,264454,,PD4417a,PD4417a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,77,
8,441570,EGAN00001000089,,GCATGGCT,,Custom,GCATGGCT,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4418a 441570,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000089,,Homo sapiens,,,,,264455,,PD4418a,PD4418a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,78,
8,441571,EGAN00001000090,,GTTAGCCT,,Custom,GTTAGCCT,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4419a 441571,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000090,,Homo sapiens,,,,,264456,,PD4419a,PD4419a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,79,
8,441572,EGAN00001000099,,GTCGCTAT,,Custom,GTCGCTAT,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4420a 441572,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000099,,Homo sapiens,,,,,264457,,PD4420a,PD4420a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,80,
8,441573,EGAN00001000092,,GGAATGAT,,Custom,GGAATGAT,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4421a 441573,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000092,,Homo sapiens,,,,,264458,,PD4421a,PD4421a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,81,
8,441574,EGAN00001000093,,GAGCCAAT,,Custom,GAGCCAAT,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4422a 441574,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000093,,Homo sapiens,,,,,264459,,PD4422a,PD4422a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,82,
8,441575,EGAN00001000094,,GCTCCTTG,,Custom,GCTCCTTG,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4423a 441575,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000094,,Homo sapiens,,,,,264460,,PD4423a,PD4423a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,83,
8,441576,EGAN00001000095,,GTAAGGTG,,Custom,GTAAGGTG,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4424a 441576,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000095,,Homo sapiens,,,,,264461,,PD4424a,PD4424a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,84,
8,441577,EGAN00001000096,,GAGGATGG,,Custom,GAGGATGG,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4425a 441577,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000096,,Homo sapiens,,,,,264462,,PD4425a,PD4425a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,85,
8,441578,EGAN00001000097,,GTTGTCGG,,Custom,GTTGTCGG,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4426a 441578,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000097,,Homo sapiens,,,,,264463,,PD4426a,PD4426a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,86,
8,441579,EGAN00001000098,,GGATTAGG,,Custom,GGATTAGG,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4427a 441579,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000098,,Homo sapiens,,,,,264464,,PD4427a,PD4427a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,87,
8,441580,EGAN00001000105,,GATAGAGG,,Custom,GATAGAGG,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4428a 441580,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000105,,Homo sapiens,,,,,264465,,PD4428a,PD4428a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,88,
8,441581,EGAN00001000100,,GTGTGTCG,,Custom,GTGTGTCG,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4429a 441581,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000100,,Homo sapiens,,,,,264466,,PD4429a,PD4429a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,89,
8,441582,EGAN00001000101,,GCAATCCG,,Custom,GCAATCCG,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4430a 441582,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000101,,Homo sapiens,,,,,264467,,PD4430a,PD4430a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,90,
8,441583,EGAN00001000102,,GACCTTAG,,Custom,GACCTTAG,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4431a 441583,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000102,,Homo sapiens,,,,,264468,,PD4431a,PD4431a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,91,
8,441584,EGAN00001000103,,GCCTGTTC,,Custom,GCCTGTTC,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4432a 441584,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000103,,Homo sapiens,,,,,264469,,PD4432a,PD4432a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,92,
8,441585,EGAN00001000104,,GCACTGTC,,Custom,GCACTGTC,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4433a 441585,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000104,,Homo sapiens,,,,,264470,,PD4433a,PD4433a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,93,
8,441586,EGAN00001000106,,GCTAACTC,,Custom,GCTAACTC,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4434a 441586,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000106,,Homo sapiens,,,,,264471,,PD4434a,PD4434a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,94,
8,441587,EGAN00001000107,,GATTCATC,,Custom,GATTCATC,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4435a 441587,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000107,,Homo sapiens,,,,,264472,,PD4435a,PD4435a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,95,
8,441588,EGAN00001000108,,GTCTTGGC,,Custom,GTCTTGGC,,las@sanger.ac.uk sm2@sanger.ac.uk snz@sanger.ac.uk,las@sanger.ac.uk snz@sanger.ac.uk,sm2@sanger.ac.uk,sm2@sanger.ac.uk,,0,0,,,PD4436a 441588,Human,9606,S0301,643,Breast Cancer Follow Up Series,standard,,,,EGAN00001000108,,Homo sapiens,,,,,264473,,PD4436a,PD4436a,,,,EGAS00001000002,1,0,0,This study%27s purpose is to use data generated in whole genome and exome Breast Cancer sequencing to target specific areas in multiple other Breast Cancer samples. These areas will then be subjected to PCR in multiple cases%2C tagged and then pool the resultant amplicons. These amplicons will then be sequenced on the Illumina GAII. This is hoped to show the prevalence of previous findings in multiple individuals in a high throughput method.,654,Breast Cancer Follow Up Series,Homo_sapiens (GRCh37_53) DO_NOT_USE,,Breast Cancer Follow Up Series,96,

